We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Read more about cookies

an image
  • Register
  • Log in
  • Language
Show submenu Hide submenu

Swedish life science takes the stage at San fransico bio

On the 6th of June, Business Sweden together with one of Europe's most significant Life Science clusters, One Nucleus (London/Cambridge), hosts a breakfast seminar at BIO in San Francisco, the world's largest biotech conference.

Topic of discussion for the first part of the seminar is how tech-companies and big pharmaceutical companies can collaborate, compete and possible merge in an era of digitalisation as new technology is being introduced. Experts from global giants Johnson & Johnson as well as Philips are present among the speakers.

The second part of the seminar includes a presentation of Sweden's strengths in Life Sciences and what Sweden can offer international players in the form of co-operation and investment opportunities and the Swedish Government’s national coordinator for Life Science will participate.

-    Through a partnership between the pharmaceutical industry and health care and technology companies we can meet the needs of more efficient equipment, intelligent health care that provides high quality at lower cost, says Ylva Berg, CEO of Business Sweden

For additional information, contact:

Elisabeth Somp, Head of Media Relations at Business Sweden

T: +46(0)72-540 93 38 E: elisabeth.somp@business-sweden.se

Business Sweden’s purpose is to help every Swedish company to reach their full international potential and companies abroad to reach their full potential through investments in Sweden. We help our customers through strategic advice and hands-on support. Business Sweden is owned by the Swedish Government and the industry. Business Sweden was founded on the first of January, 2013, by a merger of the Swedish Trade Council (Exportrådet) and Invest Sweden.


03 June 2016